Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting Phase 4 Interventional

Rezdiffra® With Concomitant Therapies Commonly Used to Treat Comorbidities in Adults With MASH and F2-F3 Fibrosis

ClinicalTrials.gov ID: NCT07848191

Public ClinicalTrials.gov record NCT07848191. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 16, 2026, 9:30 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 4, Open-label, Multi-group Study of Rezdiffra® in Combination With Concomitant Therapies Commonly Used to Treat Comorbidities in Adults With MASH and Moderate to Advanced (F2-F3) Fibrosis, Administered According to Their Approved Labeling

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To determine the safety of Rezdiffra (Resmetirom) when administered alongside common prescriptions for Diabetes Metellus (Farxiga/dapagliflozin \& Actos/pioglitazone)

Study identification

NCT ID
NCT07848191
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 4
Lead sponsor
Madrigal Pharmaceuticals, Inc.
Industry
Enrollment
150 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 7, 2026 (Actual)
Primary completion
Nov 2027 (Estimated)
Completion
Nov 2027 (Estimated)
Last update posted
Oct 16, 2026

2026 – 2027

United States locations

U.S. sites
16
U.S. states
9
U.S. cities
15
Facility City State ZIP Site status
Arizona Liver Health - Chandler Chandler Arizona 85224 Not yet recruiting
Arkansas Gastroenterology North Little Rock Arkansas 72117 Not yet recruiting
Southern California Research Center Coronado California 92118 Not yet recruiting
Inland Empire Liver Foundation Rialto California 37411 Not yet recruiting
Florida Research Institute Lakewood Rch Florida 34211 Not yet recruiting
Gastro Health PLLC Galloway Miami Florida 33176 Recruiting
Med Research of Florida, LLC Miami Florida 33186 Not yet recruiting
Elevate Clinical Research Lake Charles Louisiana 70605 Recruiting
Centricity Research - Morehead City - Multispecialty - PPDS Morehead City North Carolina 28557 Not yet recruiting
Gastro Health Research Cincinnati Ohio 45219 Recruiting
University Diabetes and Endocrine Consultants Chattanooga Tennessee 37411 Not yet recruiting
Texas Clinical Research Institute Arlington Texas 76012-3216 Not yet recruiting
South Texas Endocrinology & Metabolism Center Corpus Christi Texas 78414 Not yet recruiting
The Liver Institute at Methodist Dallas Medical Center Dallas Texas 75234 Not yet recruiting
Elevate Clinical Research - McAllen - PPDS McAllen Texas 78504 Not yet recruiting
Diabetes and Glandular Disease Clinic, PA San Antonio Texas 78229 Not yet recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07848191, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 16, 2026 · Synced Oct 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT07848191 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →